Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium.
Alkali Metals Limited (ALKALI) is listed on the NSE in the Basic Materials sector, Specialty Chemicals industry. The ALKALI share price is ₹81.28 (+3.29% today), with a market capitalisation of ₹83Cr and a price-to-earnings (P/E) ratio of 32.5. MarketRipple tracks the ALKALI investment thesis, the ripple-chain impact of market events on Alkali Metals Limited, and the Basic Materials sector outlook.
Open
₹80.99
High
₹81.40
Low
₹80.00
Prev. Close
₹78.69
52W High
₹106.30
52W Low
₹46.80
Day range
₹80.00–₹81.40
52-week range
₹46.80–₹106.30
Volume
1K
P/E
32.5
ROE
6.0%
D/E
0.41
Margin
2.6%
Alkali Metals Limited (NSE: ALKALI) is currently trading at ₹81.28 (+3.29%).
Alkali Metals Limited's market capitalization is ₹83Cr.
Alkali Metals Limited's price-to-earnings (P/E) ratio is 32.5.
Alkali Metals Limited operates in the Basic Materials sector (Specialty Chemicals).